Matthew B. Klein, CHIEF EXECUTIVE OFFICER at PTC THERAPEUTICS, INC. (PTCT), sold 8,165 shares at $77.48 ($630K) on 2026-01-07, disclosed to the SEC on 2026-01-08.
Seasonal sale ($630k) by CHIEF EXECUTIVE OFFICER — this insider has traded PTCT in January in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $76.95 | 5,149 | $396K | 62.9% |
| 2 | $77.48 | 3,016 | $234K | 37.1% |
| Total | $77.15 avg | 8,165 | $630K | 100% |
| Filing → |
| PTCT | SELL | 2026-05-15 | $917K | — | Filing → |
| PTCT | SELL | 2026-04-23 | $202K | — | Filing → |
| PTCT | SELL | 2026-03-13 | $171K | — | Filing → |